Acute Stroke: Prehospital Versus In-HospitAL Initiation of Recanalization Therapy- ASPHALT
ASPHALT
Prehospital Initiation of Reperfusion Therapy for Acute Ischemic Stroke: Randomized Medico-economic Evaluation of a Mobile Stroke Unit.
2 other identifiers
interventional
450
1 country
11
Brief Summary
ASPHALT is an academic-driven open-label randomized controlled trial of Mobile Stroke Unit (MSU) deployment versus standard care in France, with blinded assessment of efficacy endpoints. 450 patients with confirmed acute ischemic stroke will be recruited over a 3-year period, with 3-month follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Longer than P75 for not_applicable
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2022
CompletedFirst Posted
Study publicly available on registry
December 14, 2022
CompletedStudy Start
First participant enrolled
October 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 16, 2027
February 1, 2024
October 1, 2023
3 years
December 2, 2022
January 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incremental Cost-Utility Ratio (ICUR)
ICUR in the lifetime horizon, based on extrapolated results of the Modified Rankin Scale (mRS) at 3 months and incremental costs prospectively collected during the first 3 months
3 months
Key secondary outcome: Modified Rankin Scale (mRS) at 3 months
Modified Rankin scale, assessed in a blinded fashion (range, 0 to 6, with 0 indicating no disability, 3 indicating moderate disability, and 6 indicating death)
90 +/- 14 days
Secondary Outcomes (12)
ICUR at 3 months
90 +/- 14 days
ICUR at 5 years
5 years
Time from symptom onset to intravenous thrombolysis (IVT)
up to 4.5 hours from symptom onset
Time from symptom onset to mechanical thrombectomy (MT)
up to 24 hours from symptom onset
Time from alarm to IVT
up to 4.5 hours from symptom onset
- +7 more secondary outcomes
Study Arms (2)
Intervention (MSU)
EXPERIMENTALDeployment of MSU + conventional ambulance
Control (usual care)
NO INTERVENTIONDeployment of conventional ambulance
Interventions
Deployment of an MSU + conventional ambulance, allowing prehospital CT-scan imaging with intracranial CT angiography. This will allow prehospital intravenous thrombolysis and optimal triage (i.e. accurate identification of patients with large vessel occlusion, who are eligible for mechanical thrombectomy).
Eligibility Criteria
You may qualify if:
- Emergency call to one of the two following emergency medical service (EMS) dispatch centers : SAMU (Service d'Aide Médicale Urgente) or BSPP (Brigade des Sapeurs Pompiers de Paris), between 08:00 and 18:00, 5 days a week (Monday to Friday).
- Suspected acute stroke according to a dispatcher stroke identification algorithm, adapted from the ROSIER scale
- Symptom onset-to-randomization time ≤ 6h
- Patient located within the predefined catchment area of the MSU
- MSU available at the time of the EMS call
- Informed consent (as approved by the ethics committee, informed consent will be obtained after randomization: at the arrival of the MSU (intervention group), or at hospital arrival (control group))
You may not qualify if:
- Patient confined to be more than 50% of waking hours
- Unknown or uncertain onset time (e.g. wake-up stroke)
- Medical history of epilepsy
- Recent epileptic seizure (\<12 hrs)
- Suspicion of pregnancy
- Parturient or breastfeeding woman
- Patient already participating in another interventional study, which could influence the mRS at 3 months.
- Patient under guardianship or curatorship
- Patient not affiliated to French Social Security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier St Annelead
- Assistance Publique - Hôpitaux de Pariscollaborator
- Ministry of Health, Francecollaborator
Study Sites (11)
AP-HP - hôpital Raymond Poincaré
Garches, 92380, France
AP-HP - hôpital Bicêtre
Le Kremlin-Bicêtre, 94275, France
AP-HP - hôpital Lariboisière
Paris, 75010, France
AP-HP - hôpital de la Pitié-Salpêtrière
Paris, 75013, France
GHU Paris psychiatrie & neurosciences
Paris, 75014, France
SAMU 75 de Paris
Paris, 75015, France
BSPP, Brigade des Sapeurs-Pompiers de Paris
Paris, 75017, France
AP-HP - hôpital Bichat - Claude-Bernard
Paris, 75018, France
Fondation Ophtalmologique Rothschild
Paris, 75019, France
Hôpital Saint Joseph
Paris, 75674, France
Hôpital Foch
Suresnes, 92151, France
Related Publications (1)
Turc G, Hadziahmetovic M, Walter S, Churilov L, Larsen K, Grotta JC, Yamal JM, Bowry R, Katsanos AH, Zhao H, Donnan G, Davis SM, Hussain MS, Uchino K, Helwig SA, Johns H, Weber JE, Nolte CH, Kunz A, Steiner T, Sacco S, Ebinger M, Tsivgoulis G, Fassbender K, Audebert HJ. Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysis. JAMA Neurol. 2022 Mar 1;79(3):281-290. doi: 10.1001/jamaneurol.2021.5321.
PMID: 35129584BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume TURC, MD, PhD
GHU Paris Psychiatrie et Neurosciences
- STUDY DIRECTOR
Benoît VIVIEN, MD, PhD
APHP - Centre Hospitalier Universitaire Necker
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Blinded assessment of 3-month mRS (via telephone interview)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2022
First Posted
December 14, 2022
Study Start
October 16, 2023
Primary Completion (Estimated)
October 16, 2026
Study Completion (Estimated)
June 16, 2027
Last Updated
February 1, 2024
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Two years after the last publication
- Access Criteria
- Data sharing must be accepted by the sponsor and the PI based on a scientific project and scientific involvement of the PI team. Collaboration will be fostered. Data sharing must respect the agreements made with funders. Teams wishing to obtain IPD must meet the sponsor and PI team to present scientific (and commercial) purpose, IPD needed, format of data transmission, and time frame. Technical feasibility and financial support will be discussed before mandatory contractual agreement. Processing of shared data must comply with European General Data Protection Regulation (GDPR).
Individual participant data (IPD) could be available to other researcher aiming to conduct an IPD-meta analysis of studies of MSU vs. usual care (please see access criteria below).